Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

DIGOXIN Drug Profile

« Back to Dashboard
Digoxin is a drug marketed by Hikma Intl Pharms, Hospira, Abraxis Pharm, Roxane, Impax Labs, Sun Pharm Inds Inc, Stevens J, Sandoz, Mylan Pharms Inc, Wyeth Ayerst, and Eurohlth Intl Sarl. and is included in thirteen NDAs. It is available from thirty-three suppliers.

The generic ingredient in DIGOXIN is digoxin. There are nine drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the digoxin profile page.

Summary for Tradename: DIGOXIN

Suppliers / Packagers: see list33

Pharmacology for Tradename: DIGOXIN

Ingredient-typeCardiac Glycosides
Drug ClassCardiac Glycoside

Clinical Trials for: DIGOXIN

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms
TABLET;ORAL077002-002Oct 30, 2007RXNo<disabled><disabled>
INJECTABLE;INJECTION040092-001Apr 25, 1996DISCNNo<disabled><disabled>
Impax Labs
TABLET;ORAL078556-002Jul 20, 2009RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?